Showing results (711-720 of 867) with videos related to

Sort By:
Pageof 87
Journal of Substance Use and Addiction Treatment|October 22, 2023
Development and validation of a community-level social determinants of health index for drug overdose deaths in the HEALing Communities StudyNina Cesare, Lisa M Lines, Redonna Chandler, et al.
Phytopathology|May 29, 2023
Rating System for Phytophthora Root Rot Influences Quantitative Trait Locus Detection and Reveals Incomplete Dominance and Duplicative Recessive Epistatic Gene Action in Capsicum annuumDerek W Barchenger, Yu-Ming Hsu, Kuei-Jr Liao, et al.
The Journal of Clinical Endocrinology and Metabolism|December 11, 2019
Activating Mutations of the G-protein Subunit α 11 Interdomain Interface Cause Autosomal Dominant Hypocalcemia Type 2Caroline M Gorvin, Victoria J Stokes, Hannah Boon, et al.
Virology|June 19, 2002
Mechanisms of protection induced by attenuated simian immunodeficiency virusRichard J Stebbings, Neil M Almond, E Jim Stott, et al.
The Journal of Experimental Medicine|March 9, 2011
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responsesLi Wang, Rotem Rubinstein, Janet L Lines, et al.
Plos One|January 23, 2026
Applying the open-LUCIS framework to identify and characterize human-wildlife conflicts: A case study in BotswanaSilas Achidago, Changjie Chen, Jasmeet Judge, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2020
Clinical MEN-1 Among a Large Cohort of Patients With AcromegalyLisa B Nachtigall, Francisco J Guarda, Kate E Lines, et al.
The Journal of Experimental Medicine|December 4, 2002
HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cellsAmy S Heinzel, Jeff E Grotzke, Rebecca A Lines, et al.
Current Research in Parasitology & Vector-Borne Diseases|January 2, 2023
Characterizing pyrethroid resistance and mechanisms in Anopheles gambiae (s.s.) and Anopheles arabiensis from 11 districts in UgandaHenry Ddumba Mawejje, David Weetman, Adrienne Epstein, et al.
Alzheimer'S Research & Therapy|August 8, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseMichael F Egan, Yuki Mukai, Tiffini Voss, et al.
Pageof 87